TAM JAI INTL(02217) mid-term profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.
Tanzi International (02217) announced that for the six months ended September 30, 2024, it achieved revenue of 1.404 billion...
TAM JAI INTL (02217) announced that, for the six months ended September 30, 2024, the company achieved revenue of 1.404 billion Hong Kong dollars, an increase of 1.23% year-on-year; the net profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.
Related Articles
LIVZON PHARMA (01513) plans to acquire approximately 3.50% of Xinbeijiang Pharmaceutical for about 107 million yuan.
BEKE-W (02423) announced its second-quarter performance, with adjusted net profit of 3.185 billion yuan, a year-on-year increase of 74.9%.
Transformation effectiveness + stock market recovery, BEKE-W (02423) profit margin rises to 14.6%: both second-hand and new homes increase, home decoration rental controls quantity while improving quality.
LIVZON PHARMA (01513) plans to acquire approximately 3.50% of Xinbeijiang Pharmaceutical for about 107 million yuan.
BEKE-W (02423) announced its second-quarter performance, with adjusted net profit of 3.185 billion yuan, a year-on-year increase of 74.9%.
Transformation effectiveness + stock market recovery, BEKE-W (02423) profit margin rises to 14.6%: both second-hand and new homes increase, home decoration rental controls quantity while improving quality.
RECOMMEND
